Trevicta 175 mg/0.875 ml
Trevicta 175 mg/0.875 ml is a medicine authorised by Swissmedic under authorisation number 66054. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 November 2016 and the authorisation is valid without a time limit. ATC code N05AX13 places the medicine in the group Psycholeptics.
| Authorisation number | 66054 |
|---|---|
| Name | Trevicta 175 mg/0.875 ml |
| Full name | Trevicta 175 mg/0.875 ml, Depot-Injektionssuspension in einer Fertigspritze |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX13 |
| First authorisation | 16 November 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Trevicta 175 mg/0.875 ml, Depot-Injektionssuspension in einer Fertigspritze | B | 16 November 2016 |
| 2 | Trevicta 263 mg/1.315 ml, Depot-Injektionssuspension in einer Fertigspritze | B | 16 November 2016 |
| 3 | Trevicta 350 mg/1.75 ml, Depot-Injektionssuspension in einer Fertigspritze | B | 16 November 2016 |
| 4 | Trevicta 525 mg/2.625 ml, Depot-Injektionssuspension in einer Fertigspritze | B | 16 November 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 2 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 3 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
| 4 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Trevicta 175 mg/0.875 ml authorised in Switzerland?
Yes. Trevicta 175 mg/0.875 ml is authorised by Swissmedic under authorisation number 66054, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Trevicta 175 mg/0.875 ml have?
Trevicta 175 mg/0.875 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Trevicta 175 mg/0.875 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.